SCHEMBL29601231

SCHEMBL29601231

Cc1ccnc(Nc2nc(-c3ncccc3C)c(CO)s2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN1 Q92952 1/20 0.44
KCNN2 Q9H2S1 1/20 0.44
KCNN3 Q9UGI6 1/20 0.44
SLC2A1 P11166 1/20 0.43
KDR P35968 2/20 0.43
MEN1 O00255 9/20 0.41
KMT2A Q03164 9/20 0.41
NPC1 O15118 9/20 0.41
RAB9A P51151 8/20 0.41
LCK P06239 4/20 0.41
CASP3 P42574 2/20 0.41
SENP8 Q96LD8 2/20 0.41
SENP7 Q9BQF6 2/20 0.41
SENP6 Q9GZR1 2/20 0.41
POLB P06746 2/20 0.39
GAA P10253 1/20 0.39
NR2F2 P24468 1/20 0.39
MAP4K4 O95819 1/20 0.39
ABL1 P00519 1/20 0.39
FYN P06241 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27039903 1.00 KCNN1 (0.44) KCNN1KCNN2KCNN3SLC2A1KDR
SCHEMBL24358082 0.87 KCNN1 (0.42) KCNN1KCNN2KCNN3SLC2A1KDR
SCHEMBL27039759 0.84 KCNN1 (0.58) KCNN1KCNN2KCNN3SLC2A1KDR
SCHEMBL29601738 0.81 DHODH (0.50) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL27039803 0.81 DHODH (0.50) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL24358008 0.80 KDR (0.54) KCNN1KCNN2KCNN3SLC2A1KDR
SCHEMBL30745731 0.80 KDR (0.54) KCNN1KCNN2KCNN3SLC2A1KDR
SCHEMBL22599212 0.76 KDR (0.48) KCNN1KCNN2KCNN3SLC2A1KDR
SCHEMBL30000215 0.76 KDR (0.48) KCNN1KCNN2KCNN3SLC2A1KDR
SCHEMBL24357990 0.74 KCNN1 (0.70) KCNN1KCNN2KCNN3SLC2A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232449-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-08-30 EP disclosed
WO-2022087326-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-04-28 WO disclosed